Sandoz Group AG (MEX:SDZN) 9-Day RSI: N/A (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:SDZN Sandoz Group AG MEX:SDZN
27 GF Score
Price MXN1,481.70
GF Value MXN988.01
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-08-12), Sandoz Group AG's 9-Day RSI is N/A.

The industry rank for Sandoz Group AG's 9-Day RSI or its related term are showing as below:

MEX:SDZN's 9-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 56.01
* Ranked among companies with meaningful 9-Day RSI only.

Sandoz Group AG  (MEX:SDZN) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

Sandoz Group AG 9-Day RSI Related Terms

MEX:SDZN vs ZTS, UTHR, VTRS: 9-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG 9-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's 9-Day RSI falls into.


MEX:SDZN
27GF Score
Sandoz Group AG MEX:SDZN
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG  (MEX:SDZN) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Sandoz Group AG (MEX:SDZN) Overvalued in 2026?

Based on GuruFocus' analysis, Sandoz Group AG stock appears to be overvalued. The current stock price of MXN1,481.70 is trading 50% above its estimated GF Value™ of MXN988.01.

Key valuation signals for MEX:SDZN:

  • 9-Day RSI: N/A
  • GF Value™: MXN988.01 vs. price of MXN1,481.70 (50% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the MEX:SDZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
27GF Score

Get the complete analysis for MEX:SDZN

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,481.70
Price
MXN988.01
GF Value